January 2, 2025 - Health Technology Insights

January 2, 2025
HealthTech Media Room
Cancer, Health, Health Services, HealthTech News

Final Rounds of Late-Breaking Clinical Trial Results Announced at VIVA24

VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds of Late-Breaking...

January 2, 2025
HealthTech Media Room
Cancer, General Healthcare Services, Health, HealthTech News

Two Data Analyses From Clinical Trials Show Epcoritamab Induces Durable Complete Reponses

AbbVie announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult patients with diffuse large B-cell lymphoma (DLBCL) at the...

January 2, 2025
HealthTech Media Room
Clinical Trials, Health, Health Analytics, HealthTech News

HKBU’s Aptamer for X-Linked Hypophosphatemia Receives Orphan Drug Status

A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People’s Hospital Affiliated to School of Medicine at Shanghai Jiao Tong University (Shanghai Sixth People’s Hospital) has discovered...

January 2, 2025
HealthTech Media Room
Clinical Trials, Health, HealthTech News

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Traws Pharma, a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of respiratory viral diseases, today announced progress in the development of its investigational one-dose influenza...

January 2, 2025
HealthTech Media Room
Analytics & AI, Cancer, Health, HealthTech News

Oncolytics Biotech Highlights 2024 Milestones, Prepares for 2025

Oncolytics Biotech, a leading clinical-stage company specializing in immunotherapy for oncology, is providing a recap of the major accomplishments from 2024 and a preview of the milestones that are expected over the...

January 2, 2025
HealthTech Media Room
Clinical Trials, Health, HealthTech News, Surgical & Advanced Therapies

NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS

NeuroSense Therapeutics Ltd, a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, announced that it has entered into a binding term sheet with a leading global...

January 2, 2025
HealthTech Media Room
Clinical Trials, HealthTech News, Medical Technology

Sumitomo Pharma America Announces FDA Approval of GEMTESA for Overactive Bladder

Sumitomo Pharma America, announced today that the U.S. Food and Drug Administration (FDA) has approved GEMTESA (vibegron), a beta-3 (β3) adrenergic receptor agonist, dosed once-daily (75 mg), for the treatment...

Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis

January 2, 2025
HealthTech Media Room
Clinical Trials, Health, HealthTech News, Medical Research Software

Keymed Biosciences Announces Approval of Stapokibart for Chronic Rhinosinusitis

Keymed Biosciences, announced the National Medical Products Administration of China has recently approved the supplemental New Drug Application of Stapokibart, for the treatment of chronic rhinosinusitis with nasal polyposis. HealthTech Insights: How...

January 2, 2025
HealthTech Media Room
Allergy Treatments, Cancer, Clinical Trials, General Healthcare Services, HealthTech News

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the transformative potential of innovative therapies to improve patient outcomes. A stage 4 breast cancer patient in the United...

Final Rounds of Late-Breaking Clinical Trial Results Announced at VIVA24

Two Data Analyses From Clinical Trials Show Epcoritamab Induces Durable Complete Reponses

HKBU’s Aptamer for X-Linked Hypophosphatemia Receives Orphan Drug Status

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Oncolytics Biotech Highlights 2024 Milestones, Prepares for 2025

NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS

Sumitomo Pharma America Announces FDA Approval of GEMTESA for Overactive Bladder

Keymed Biosciences Announces Approval of Stapokibart for Chronic Rhinosinusitis

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands